Search research articles
Contact Us
Filters
Showing results (11-20 of 67) with videos related to
Page
of 7
Sort By:
Epidemiologia E Prevenzione
|
May 19, 2018
[Conflict of interest and public health body: the bias and the rule]
Giuseppe Traversa, Mauro Venegoni
Global & Regional Health Technology Assessment
|
June 12, 2026
Comments on: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis
Giuseppe Traversa, Antonio Addis
Journal of Medical Ethics
|
August 11, 2025
What if all participants get the same treatment? An ethical perspective on single arm trials
Chiara Mannelli, Giuseppe Traversa
Epidemiologia E Prevenzione
|
August 2, 2018
[Adaptive studies to assess drug effectiveness]
Paolo Bruzzi, Giuseppe Traversa
Epidemiologia E Prevenzione
|
September 26, 2015
[Vaccines are drugs]
Giuseppe Traversa, Roberto Raschetti
Recenti Progressi in Medicina
|
October 27, 2016
[Biomedical research from philanthropy to scarcity.]
Antonio Addis, Luca De Fiore, Giuseppe Traversa
Orphanet Journal of Rare Diseases
|
April 13, 2016
Italian program for independent research on drugs: 10 year follow-up of funded studies in the area of rare diseases
Giuseppe Traversa, Lucia Masiero, Luciano Sagliocca, et al.
Recenti Progressi in Medicina
|
June 27, 2013
[The role of drug registries in the post-marketing surveillance]
Giuseppe Traversa, Luciano Sagliocca, Nicola Magrini, et al.
Recenti Progressi in Medicina
|
June 27, 2013
[A perspective for the role of drug registries in the post-marketing surveillance]
Giuseppe Traversa, Luciano Sagliocca, Nicola Magrini, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
January 6, 2016
Switching Between Epoetins: A Practice in Support of Biosimilar Use
Carmen D'Amore, Roberto Da Cas, Mariangela Rossi, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 67) with videos related to
Sort By:
Page
of 7
Epidemiologia E Prevenzione
|
May 19, 2018
[Conflict of interest and public health body: the bias and the rule]
Giuseppe Traversa, Mauro Venegoni
Global & Regional Health Technology Assessment
|
June 12, 2026
Comments on: Italian Medicines Agency's reform and time until pricing and reimbursement decisions: a time-to-event analysis
Giuseppe Traversa, Antonio Addis
Journal of Medical Ethics
|
August 11, 2025
What if all participants get the same treatment? An ethical perspective on single arm trials
Chiara Mannelli, Giuseppe Traversa
Epidemiologia E Prevenzione
|
August 2, 2018
[Adaptive studies to assess drug effectiveness]
Paolo Bruzzi, Giuseppe Traversa
Epidemiologia E Prevenzione
|
September 26, 2015
[Vaccines are drugs]
Giuseppe Traversa, Roberto Raschetti
Recenti Progressi in Medicina
|
October 27, 2016
[Biomedical research from philanthropy to scarcity.]
Antonio Addis, Luca De Fiore, Giuseppe Traversa
Orphanet Journal of Rare Diseases
|
April 13, 2016
Italian program for independent research on drugs: 10 year follow-up of funded studies in the area of rare diseases
Giuseppe Traversa, Lucia Masiero, Luciano Sagliocca, et al.
Recenti Progressi in Medicina
|
June 27, 2013
[The role of drug registries in the post-marketing surveillance]
Giuseppe Traversa, Luciano Sagliocca, Nicola Magrini, et al.
Recenti Progressi in Medicina
|
June 27, 2013
[A perspective for the role of drug registries in the post-marketing surveillance]
Giuseppe Traversa, Luciano Sagliocca, Nicola Magrini, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
January 6, 2016
Switching Between Epoetins: A Practice in Support of Biosimilar Use
Carmen D'Amore, Roberto Da Cas, Mariangela Rossi, et al.
Page
of 7